Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05616949 · ClinicalTrials.gov registry record · NA
Peer Recovery Support Services for Individuals in Recovery Residences on MOUD
A NA study of Opioid Use Disorder and Substance Use Disorder, sponsored by Potomac Health Foundations.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT05616949 is a NA study of Opioid Use Disorder and Substance Use Disorder that is active but no longer recruiting, run by Potomac Health Foundations. The registered enrollment target is 50 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05616949, a NA study of Opioid Use Disorder and Substance Use Disorder, is active but no longer recruiting, sponsored by Potomac Health Foundations.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
The United States is experiencing an unprecedented opioid epidemic with a rapid increase in overdose deaths. Medications for opioid use disorder (MOUD) including methadone, buprenorphine, and extended-release naltrexone are efficacious and the recommended standard of care, yet barriers to sustained MOUD treatment reduce the overall efficacy of MOUD. Rates of MOUD retention are alarmingly low and MOUD dropout predicts opioid use/relapse, overdose, and death. While previous research has identified predictors of MOUD retention and adherence, there are no evidence-based interventions to improve MOUD retention. Recovery support services are a broad set of strategies to promote healthy outcomes among individuals with substance use disorder (SUD) that are typically separate from standard professional treatment. Among those strategies most utilized are peer recovery support services (PRSS) and recovery residences (RRs). PRSS include coaching, mentoring, education, and other supports delivered by individuals uniquely qualified by their lived experience with SUD. PRSS are increasingly utilized in a range of clinical settings, and advantages of PRSS include inherent shared understanding of addiction and a high degree of acceptance and understanding that is not found in most professional relationships. Existing research tentatively supports PRSS; however, the evidence to date is sparse and comes with significant methodological limitations and inconsistencies that make it difficult to conclude the efficacy of PRSS. No studies have examined the role of PRSS in promoting retention in MOUD. RRs provide a supportive living environment for persons in recovery from SUD and are widely utilized in the United States with an estimated 17,943 residences in 2020. Despite their proliferation, the evidence for RRs is only moderate and diminished by methodological weaknesses. Further, individuals on MOUD seeking housing through RRs often face increased MOUD-related stigma or may be disqualifi
Conditions Studied
Interventions
- BEHAVIORAL Treatment as Usual (TAU) (Arm 1)
- BEHAVIORAL Peer Recovery Support Services (PRSS) + TAU (experimental- Arm 2)
Study Locations (2)
Maryland
- Maryland Treatment Centers - Baltimore
- Maryland Treatment Centers/Avery Road Treatment Center - Rockville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-07-14 |
| Est. Completion | 2025-09-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05616949
The ClinicalTrials.gov registry entry for NCT05616949 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is Potomac Health Foundations, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual (TAU) (Arm 1) is the first listed.
NCT05616949 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT05616949 about?
NCT05616949 is a clinical study titled "Peer Recovery Support Services for Individuals in Recovery Residences on MOUD". The United States is experiencing an unprecedented opioid epidemic with a rapid increase in overdose deaths. Medications for opioid use disorder (MOUD) including methadone, buprenorphine, and extended-release naltrexone are efficacious and the recommended standard of care, yet barriers to sustained ...
What is the current status of trial NCT05616949?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-07-14. Estimated completion is 2025-09-29.
What conditions does trial NCT05616949 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Substance Use Disorder.
What interventions are being tested in trial NCT05616949?
The interventions under investigation include: Treatment as Usual (TAU) (Arm 1) (BEHAVIORAL), Peer Recovery Support Services (PRSS) + TAU (experimental- Arm 2) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05616949?
This trial is sponsored by Potomac Health Foundations, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05616949 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.